Bryn Pharma Research on Epinephrine Nasal Spray Presented at The American College of Allergy, Asthma and Immunology Annual Meeting

HOUSTON, Nov. 10, 2019 /PRNewswire/ — Bryn Pharma, LLC (“Bryn” or the “Company”), a privately held pharmaceutical company dedicated to finding a better way for patients and caregivers to treat anaphylaxis, announced that the results of two studies supporting the potential benefits of its…

from PR Newswire: https://ift.tt/36SYbMO
via IFTTT

Nektar Therapeutics Presents Data from First-in-Human Phase 1a Study on Novel T Regulatory Cell Stimulator, NKTR-358 at 2019 Annual Meeting of the American College of Rheumatology

SAN FRANCISCO, Nov. 10, 2019 /PRNewswire/ — Nektar Therapeutics (NASDAQ: NKTR) today announced updated results from the first-in-human Phase 1a study of NKTR-358, a novel T regulatory (Treg) cell stimulator in development for the treatment of autoimmune and other chronic inflammatory…

from PR Newswire: https://ift.tt/2Q7ZGAX
via IFTTT